Citation Tools
Clinical/translational cancer immunotherapy
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG